• 1
    Karnib HH, Badr KF. Microvascular diseases of the kidney. In: BarryM, ed. The Kidney, 7th edition. Brenner , Philadelphia : W.B. Saunders, 2004: 16071610.
  • 2
    Steen VD. Scleroderma renal crisis. Rheum Dis Clin North Am 2003; 29: 315333.
  • 3
    Steen VD, Costantino JP, Shapiro AP, Medsger TA Jr. Outcome of renal crisis in systemic sclerosis: Relation to availability of angiotensin converting enzyme (ACE) inhibitors. Ann Intern Med 1990; 113: 352357.
  • 4
    Steen VD, Medsger TA Jr. Long-term outcomes of scleroderma renal crisis. Ann Intern Med 2000; 133: 600603.
  • 5
    Shor R, Halabe A. New trends in the treatment of scleroderma renal crisis. Nephron 2002; 92: 716718.DOI: 10.1159/000064073
  • 6
    Nissenson AR, Port FK. Outcome of end-stage renal disease in patients with rare causes of renal failure. III. Systemic/vascular disorders. Q J Med 1990; 74: 6374.
  • 7
    Tsakiris D, Simpson HK, Jones EH et al. Report on management of renal failure in Europe, XXVI, 1995. Rare diseases in renal replacement therapy in the ERA-EDTA Registry. Nephrol Dial Transplant 1996; 11(Suppl. 7): 420.
  • 8
    Jones B, Trevillian P, Lake N. Continuous ambulatory peritoneal dialysis in scleroderma. Nephron 1990; 54: 107108.
  • 9
    Cantaluppi A. CAPD and systemic diseases. Clin Nephrol 1988; 30(Suppl. 1): S812.
  • 10
    Woodhall PB, McCoy RC, Gunnells JC, Seigler HF. Apparent recurrence of progressive systemic sclerosis in a renal allograft. JAMA 1976; 236: 10321034.DOI: 10.1001/jama.236.9.1032
  • 11
    Merino GE, Sutherland DE, Kjellstrand CM, Simmons RL, Najarian JS. Renal transplantation for progressive systemic sclerosis with renal failure: Case report and review of previous experience. Am J Surg 1977; 133: 745749.DOI: 10.1016/0002-9610(77)90170-2
  • 12
    Javier R, Dumler F, Levin NW. Renal scleroderma: Comparison of different modalities of treatment. South Med J 1980; 73: 657659.
  • 13
    Paul M, Bear RA, Sugar L. Renal transplantation in scleroderma. J Rheumatol 1984; 11: 406408.
  • 14
    Caplin NJ, Dikman S, Winston J, Spiera H, Uribarri J. Recurrence of scleroderma in a renal allograft from an identical twin sister. Am J Kidney Dis 1999; 33: 1-4.
  • 15
    Ruiz JC, Val F, De Francisco AL et al. Progressive systemic sclerosis and renal transplantation: A contraindication to the use of cyclosporine A Transplant Proc 1991; 23: 22112212.
  • 16
    Denton CP, Sweny P, Abdulla A. Black CM. Acute renal failure occurring in scleroderma treated with cyclosporin A: A report of three cases. Br J Rheumatol 1994; 33: 9092.
  • 17
    Bleyer AJ, Donaldson LA, McIntosh M, Adams PL. Relationship between underlying renal disease and renal transplantation outcome. Am J Kidney Dis 2001; 37: 11521161.
  • 18
    Chang YJ, Spiera H. Renal transplantation in scleroderma. Medicine (Baltimore) 1999; 78: 382385.
  • 19
    McSweeney PA, Nash RA, Sullivan KM et al. High-dose immunosuppressive therapy for severe systemic sclerosis: Initial outcomes. Blood 2002; 100: 16021610.
  • 20
    Wolfe RA, Ashby VB, Milford EL et al. Comparison of mortality in all patients on dialysis, patients on dialysis awaiting transplantation, and recipients of a first cadaveric transplant. N Engl J Med 1999; 23: 17251730.DOI: 10.1056/NEJM199912023412303
  • 21
    US Renal Data System: Excerpts from the USRDS 2002 annual data report: Atlas of end-stage renal disease in the United States. Am J Kidney Dis 2003; 41(Suppl. 2): S160161.
  • 22
    Filaci G, Cutolo M, Basso M et al. Long-term treatment of patients affected by systemic sclerosis with cyclosporin A. Rheumatology (Oxford) 2001; 40: 14311432.
  • 23
    Clements PJ, Lachenbruch PA, Sterz M et al. Cyclosporine in systemic sclerosis. Results of a forty-eight-week open safety study in ten patients. Arthritis Rheum 1993; 36: 7583.
  • 24
    Stratton RJ, Wilson H, Black CM. Pilot study of anti-thymocyte globulin plus mycophenolate mofetil in recent-onset diffuse scleroderma. Rheumatology (Oxford) 2001; 40: 8488.
  • 25
    Apras S, Ertenli I, Ozbalkan Z et al. Effects of oral cyclophosphamide and prednisolone therapy on the endothelial functions and clinical findings in patients with early diffuse systemic sclerosis. Arthritis Rheum 2003; 48: 22562261.DOI: 10.1002/art.11081
  • 26
    Artlett CM, Cox LA, Ramos RC et al. Increased microchimeric CD4+ T lymphocytes in peripheral blood from women with systemic sclerosis. Increased microchimeric CD4+ T lymphocytes in peripheral blood from women with systemic sclerosis.
  • 27
    Clements P, Lachenbruch P, Siebold J et al. Inter and intraobserver variability of total skin thickness score (modified Rodnan TSS) in systemic sclerosis. J Rheumatol 1995; 22: 12811285.
  • 28
    Wood KJ. Passenger leukocytes and microchimerism: What role in tolerance induction Transplantation 2003; 75: 17S20S.DOI: 10.1097/01.TP.0000067946.90241.2F
  • 29
    Hariharan S, Johnson CP, Bresnahan BA et al. Improved graft survival after renal transplantation in the United States, 1988 to 1996. N Engl J Med 2000; 342: 605612.DOI: 10.1056/NEJM200003023420901